1. Home
  2. CRGX vs CSV Comparison

CRGX vs CSV Comparison

Compare CRGX & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • CSV
  • Stock Information
  • Founded
  • CRGX 2021
  • CSV 1991
  • Country
  • CRGX United States
  • CSV United States
  • Employees
  • CRGX N/A
  • CSV N/A
  • Industry
  • CRGX
  • CSV Other Consumer Services
  • Sector
  • CRGX
  • CSV Consumer Discretionary
  • Exchange
  • CRGX Nasdaq
  • CSV Nasdaq
  • Market Cap
  • CRGX 621.4M
  • CSV 616.5M
  • IPO Year
  • CRGX 2023
  • CSV 1996
  • Fundamental
  • Price
  • CRGX $13.46
  • CSV $39.62
  • Analyst Decision
  • CRGX Strong Buy
  • CSV Strong Buy
  • Analyst Count
  • CRGX 6
  • CSV 2
  • Target Price
  • CRGX $31.80
  • CSV $45.00
  • AVG Volume (30 Days)
  • CRGX 231.3K
  • CSV 78.3K
  • Earning Date
  • CRGX 03-20-2025
  • CSV 02-19-2025
  • Dividend Yield
  • CRGX N/A
  • CSV 1.14%
  • EPS Growth
  • CRGX N/A
  • CSV 15.90
  • EPS
  • CRGX N/A
  • CSV 2.23
  • Revenue
  • CRGX N/A
  • CSV $405,332,000.00
  • Revenue This Year
  • CRGX N/A
  • CSV $6.46
  • Revenue Next Year
  • CRGX N/A
  • CSV $4.11
  • P/E Ratio
  • CRGX N/A
  • CSV $17.76
  • Revenue Growth
  • CRGX N/A
  • CSV 7.34
  • 52 Week Low
  • CRGX $10.91
  • CSV $22.96
  • 52 Week High
  • CRGX $33.92
  • CSV $42.13
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 47.00
  • CSV 50.13
  • Support Level
  • CRGX $12.51
  • CSV $39.67
  • Resistance Level
  • CRGX $15.75
  • CSV $41.11
  • Average True Range (ATR)
  • CRGX 1.09
  • CSV 0.83
  • MACD
  • CRGX 0.17
  • CSV -0.03
  • Stochastic Oscillator
  • CRGX 52.74
  • CSV 49.32

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum crypts, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: